Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  WuXi AppTec Co., Ltd.    603259   CNE1000031K4

WUXI APPTEC CO., LTD.

(603259)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
02/22/2021 02/23/2021 02/24/2021 02/25/2021 02/26/2021 Date
157.3 155 148.32 147.2 143.68 Last
31633940 20530990 26654340 16761120 19908090 Volume
-9.06% -1.46% -4.31% -0.76% -2.39% Change
Financials
Sales 2020 16 514 M 2 551 M 2 551 M
Net income 2020 2 913 M 450 M 450 M
Net cash position 2020 6 540 M 1 010 M 1 010 M
P/E ratio 2020 118x
Yield 2020 0,25%
Sales 2021 21 531 M 3 326 M 3 326 M
Net income 2021 3 810 M 589 M 589 M
Net cash position 2021 6 949 M 1 073 M 1 073 M
P/E ratio 2021 88,5x
Yield 2021 0,34%
Capitalization 349 B 53 955 M 53 956 M
EV / Sales 2020 20,8x
EV / Sales 2021 15,9x
Nbr of Employees 25 743
Free-Float 54,8%
More Financials
Company
WuXi AppTec Co., Ltd. specializes in providing a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and biotech industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Net sales break down by activity as follows: - laboratory services (65,7%): small molecules discovery services, bioanalytical services, medical devices safety testing... 
More about the company
Notations Surperformance© of WuXi AppTec Co., Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about WUXI APPTEC CO., LTD.
02/19WUXI APPTEC : Nomura Adjusts Wuxi Apptec's Price Target to HK$270 From HK$129, K..
MT
02/10Contract Research Organization (CRO) Market Hit $ 68,198.3 Mn in 2025 & to gr..
AQ
01/11WUXI APPTEC : Atlantic Healthcare to attend WuXi Global Forum, January 11-13th 2..
AQ
2020WUXI APPTEC : Closes BuyBack and Cancellation of A Shares
MT
2020PRESS RELEASE : ViGeneron and WuXi Advanced Therapies enter Strategic Manufactur..
DJ
2020WUXI APPTEC : Invests $21 Million in Biotech Startup; Shares Slide
MT
2020WUXI APPTEC : Third-Quarter Net Profit Fell on Higher Costs
DJ
2020WUXI APPTEC CO., LTD. : quaterly earnings release
2020WUXI APPTEC CO., LTD. : 3rd quarter report
CO
2020WUXI APPTEC : Next Day Disclosure Return
PU
2020WUXI APPTEC : Exercise of share options granted under the reserved grant of the ..
PU
2020WUXI APPTEC : Inside information proposed disposal of a shares by a shareholder
PU
2020SIRONA BIOCHEM : Contracts WuXi AppTec for Large-Scale Manufacturing of TFC-1067
AQ
2020WUXI APPTEC : Articles of association
PU
2020WUXI APPTEC : (1) poll results of the first extraordinary general meeting of 202..
PU
More news
News in other languages on WUXI APPTEC CO., LTD.
2020WUXI APPTEC CO., LTD. : Veröffentlichung des Quartalsergebnisses
2020WUXI APPTEC CO., LTD. : publication des résultats trimestriels
2020WUXI APPTEC CO., LTD. : Veröffentlichung des Halbjahresergebnisses
2020WUXI APPTEC CO., LTD. : publication des résultats semestriels
2020WUXI APPTEC CO., LTD. : Veröffentlichung des Jahresergebnisses
More news
Analyst Recommendations on WUXI APPTEC CO., LTD.
More recommendations
Chart WUXI APPTEC CO., LTD.
Duration : Period :
WuXi AppTec Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WUXI APPTEC CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Average target price 168,34 CNY
Last Close Price 143,68 CNY
Spread / Highest target 52,2%
Spread / Average Target 17,2%
Spread / Lowest Target -22,5%
EPS Revisions
Managers and Directors
NameTitle
Ge Li Chairman, President & Co-Chief Executive Officer
Qing Yang Co-CEO, Executive Director & Executive VP
Ellis Chu Chief Financial Officer & Senior Vice President
Harry He Chairman-Supervisory Board
Frederick H. Hausheer Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
WUXI APPTEC CO., LTD.6.65%53 955
GILEAD SCIENCES, INC.7.78%76 967
VERTEX PHARMACEUTICALS-10.07%55 255
REGENERON PHARMACEUTICALS-6.19%46 924
BEIGENE, LTD.23.84%29 313
BIONTECH SE33.75%26 253